VOR Research and Charts

VOR - Vor Biopharma Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-10-29)

Last 25.50	Change ⇓ -1.43 (-5.31%)	Volume 953,263
	Open 26.79	High 26.80	Low 23.12

8EMA (Daily) 27.84	40EMA (Daily) 23.59	50EMA (Daily) 21.37	STO (Daily) 10.931	MACD Hist (Daily) -1.357
8EMA (Weekly) 24.250	40EMA (Weekly) 9.78	50EMA (Weekly) 8.33	STO (Weekly) 58.767	MACD Hist (Weekly) 1.234


Company Profile
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.